Literature DB >> 21627636

Opioids and the immune system: what is their mechanism of action?

Toby K Eisenstein1.   

Abstract

There is a significant amount of literature showing that morphine and other opioids modulate immune responses. The findings support many mechanisms by which this may occur. In vitro experiments provide evidence for direct actions of opioids on immune cells using a variety of functional end points. When these drugs are given in vivo, a plethora of immune parameters are also altered. The paper in this issue of the journal by Zhang et al. provides new information on morphine alteration of immune cell subsets in the spleen and thymus of mice and the potential role of glucocorticoids in these observed phenomena. This Commentary reviews the in vitro activities of morphine on leucocytes, as well as other documented mechanisms by which morphine can alter immune function in vivo.
© 2011 The Author. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627636      PMCID: PMC3246707          DOI: 10.1111/j.1476-5381.2011.01513.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Opioid receptor expression and function.

Authors:  Burt M Sharp
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

2.  Involvement of brain opiate receptors in the immune-suppressive effect of morphine.

Authors:  Y Shavit; A Depaulis; F C Martin; G W Terman; R N Pechnick; C J Zane; R P Gale; J C Liebeskind
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages.

Authors:  Nilka Tomassini; Fernando L Renaud; Sabita Roy; Horace H Loh
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

4.  Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors.

Authors:  L R Flores; M C Hernandez; B M Bayer
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

5.  Morphine directs T cells toward T(H2) differentiation.

Authors:  S Roy; S Balasubramanian; S Sumandeep; R Charboneau; J Wang; D Melnyk; G J Beilman; R Vatassery; R A Barke
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

6.  Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Authors:  Chang-Jiang Guo; Yuan Li; Sha Tian; Xu Wang; Steven D Douglas; Wen-Zhe Ho
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

7.  Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells.

Authors:  M A Wetzel; A D Steele; T K Eisenstein; M W Adler; E E Henderson; T J Rogers
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

8.  Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis.

Authors:  Pravin C Singhal; Madhu Bhaskaran; Jaimita Patel; Kalpesh Patel; Balakuntalam S Kasinath; Senthil Duraisamy; Nicholas Franki; Krishna Reddy; Aditi A Kapasi
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.

Authors:  Imre Szabo; Michele A Wetzel; Ning Zhang; Amber D Steele; David E Kaminsky; Chongguang Chen; Lee-Yuan Liu-Chen; Filip Bednar; Earl E Henderson; O M Zack Howard; Joost J Oppenheim; Thomas J Rogers
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

10.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

Authors:  Amber D Steele; Earl E Henderson; Thomas J Rogers
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

View more
  11 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 2.  Erector Spinae Plane Block for Lumbar Spinal Surgery: A Systematic Review.

Authors:  Yong Qiu; Teng-Jiao Zhang; Zhen Hua
Journal:  J Pain Res       Date:  2020-07-01       Impact factor: 3.133

3.  The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.

Authors:  Jermaine D Jones; Maria A Sullivan; Jeanne M Manubay; Shanthi Mogali; Verena E Metz; Roberto Ciccocioppo; Sandra D Comer
Journal:  Physiol Behav       Date:  2015-10-09

4.  The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety.

Authors:  Jermaine D Jones; Adam Bisaga; Verena E Metz; Jeanne M Manubay; Shanthi Mogali; Roberto Ciccocioppo; Gabriela Madera; Molly Doernberg; Sandra D Comer
Journal:  J Psychoactive Drugs       Date:  2018-09-11

5.  Morphine Withdrawal Enhances HIV Infection of Macrophages.

Authors:  Xu Wang; Jinbiao Liu; Lina Zhou; Wen-Zhe Ho
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

Review 6.  The Role of Opioid Receptors in Immune System Function.

Authors:  Toby K Eisenstein
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

7.  Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder.

Authors:  Breanne E Biondi; Subhasis Mohanty; Brent Vander Wyk; Ruth R Montgomery; Albert C Shaw; Sandra A Springer
Journal:  Contemp Clin Trials Commun       Date:  2021-01-06

8.  Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.

Authors:  Xu Wang; Tong-Cui Ma; Jie-Liang Li; Yu Zhou; Ellen B Geller; Martin W Adler; Jin-Song Peng; Wang Zhou; Dun-Jin Zhou; Wen-Zhe Ho
Journal:  Front Microbiol       Date:  2015-11-04       Impact factor: 5.640

9.  Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.

Authors:  Alexandra L Whittaker; Kerry A Lymn; Georgia L Wallace; Gordon S Howarth
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

Review 10.  Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update About the Dynamic Interplay of Microbes.

Authors:  Juan Antonio Gimenez-Bastida; Lucia Martinez Carreras; Angela Moya-Pérez; José Moisés Laparra Llopis
Journal:  J Pharm Sci       Date:  2017-10-26       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.